Reproduction permitted for personal use only. For reprints and reprint permission, contact

Promega partners with German biotech Amaxa

Madison, Wis.Promega Corp., which provides diverse products for the life sciences, announced an agreement with German firm Amaxa. The two firms plan to develop applications for monitoring signals between cells that are hard to reach using other techniques, such as stem cells, cancer cells and primary cells.

"The combination of Promega and Amaxa technologies will enable researchers to obtain much more significant results with physiologically relevant cells rather than more artificial cell lines”, Rainer Christine, co-founder and CEO of Amaxa, said in a press release.

-Add Your Comment


Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and are not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact

WTN Media Presents